2 SUMMARY GTP cyclohydrolase I feedback regulatory protein (GFRP) is a 9.7 kDa protein regulating GTP cyclohydrolase I activity in dependence of tetrahydrobiopterin and phenylalanine concentrations, thus enabling stimulation of tetrahydrobiopterin biosynthesis by phenylalanine to ensure its efficient metabolism by phenylalanine hydroxylase. Here, we were interested in regulation of GFRP expression by proinflammatory cytokines and stimuli, which are known to induce GTP cyclohydrolase I expression. Recombinant human GFRP stimulated recombinant human GTP cyclohydrolase I in presence of phenylalanine, and mediated feedback inhibition by tetrahydrobiopterin. Levels of GFRP mRNA in human myelomonocytoma (THP-1) cells remained unaltered by treatment of cells with interferongamma or interleukin-1ß, but were significantly down-regulated by bacterial lipopolysaccharide (LPS, 1 µg/ml), without or with cotreatment by interferon-gamma, which strongly upregulated GTP cyclohydrolase I expression and activity. GFRP expression was also suppressed in human umbilical vein endothelial cells treated with 1 µg/ml LPS, as well as in rat tissues 7 ho urs post intraperitoneal injection of 10 mg/kg LPS. THP-1 cells stimulated with interferon-gamma alone showed increased pteridine synthesis by addition of phenylalanine to the culture medium. Cells stimulated with interferon-gamma plus LPS, in contrast, showed phenylalanine-independent pteridine synthesis. These results demonstrate that LPS down-regulates expression of GFRP, thus rendering pteridine synthesis independent of metabolic control by phenylalanine.
INTRODUCTION
GTP cyclohydrolase I (E.C. 3.5.4.16 ) is the first and key enzyme of tetrahydrobiopterin biosynthesis. Tetrahydrobiopterin is required as cofactor for certain hydroxylases, including phenylalanine-4-, tyrosine-3-, tryptophan-5-, and glyceryl ether-monooxygenase, as well as nitric oxide synthase (1) . To ensure efficient degradation of phenylalanine by phenylalanine hydroxylase, GTP cyclohydrolase I activity and hence tetrahydrobiopterin biosynthesis is stimulated by phenylalanine, but not by other substrates of tetrahydrobiopterin-dependent enzymes. On a molecular level, this regulation is achieved by a small (9.7 kDa) regulatory protein associated with GTP cyclohydrolase I (2 -4), which has been termed GTP cyclohydrolase I feedback regulatory protein (GFRP) 1 . Thus, the tetrahydrobiopterin requirement for phenylalanine metabolism, which on a quantitative basis is more demanding than for e.g. nitric oxide synthesis (5) , is met by this finely tuned system.
In addition to the metabolic roles mentioned above, GTP cyclohydrolase I is induced by proinflammatory cytokines in a number of cells and tissues (6, 7) . On a molecular level, this regulation is achieved by increased transcription/translation yielding increased GTP cyclohydrolase I protein levels (8, 9). A role for this induction of GTP cyclohydrolase I by proinflammatory stimuli is the supply of sufficient tetrahydrobiopterin for the abundant formation of nitric oxide by the inducible isoform of nitric oxide synthase, which is induced in parallel (7, 10).
In the present work we investigated the role of GFRP in cytokine-induced Human recombinant GTP cyclohydrolase I was obtained by expression in pET16b and purification with DEAE cellulose and hydroxylapatite columns as described (9). For GTP cyclohydrolase I incubations, standard GTP cyclohydrolase I assay buffer (11), i.e. 0.05 M Tris.HCl, pH 7.8, containing 0.3 M KCl , 2.5. mM EDTA and 10% (v/v) glycerol was used.
In a total volume of 110 µl, 2 mM GTP was incubated with 16 pmol/min GTP cyclohydrolase I and 40 µg bacterial lysate containing human recombinant GFRP (see above), with or without addition of 9.1 µM to 455 µM tetrahydrobiopterin . In some experiments Lphenylalanine, L-tyrosine, L-tryptophan or L-arginine were added (2 mM each). After incubation for 45 min at 37 °C, the incubation mixture was oxidised with acidic iodine, centrifuged, neutralized, incubated with alkaline phosphatase and the resulting neopterin determined by HPLC with fluorescence detection as detailed elsewhere (11). 6 hours. Total RNA was prepared and GFRP mRNA quantified by real-time PCR as outlined below. Cell viability was assayed with a formazan dye reduction assay (MTT, Promega, Heidelberg, Germany). Human umbilical vein endothelial cells (HUVEC) were isolated using 0.05% collagenase, cultivated in M199 with 15% fetal calf serum, 5% human serum and 7.5 µg/ml endothelial growth supplement, stimulated with the indicated agents for 6 hours, and collected as described (12). RNA was then prepared as detailed below.
Animal experiments
The experimental protocol was approved by the local Committee on Animal Experiments of the Viennese government, and the care and handling of the animals were undertaken in accordance with the National Institutes of Health guidelines. Male Sprague Dawley rats (240 g -260 g) were used. All animals had free access to normal food and water throughout the experiment. Six animals per group were used. Endotoxin from Escherichia coli O26:B6
(Difco, Detroit, MI, U.S.A.) was dissolved in 0.9 % (w/v) NaCl, and injected intraperitoneally (10 mg/kg), controls received no treatment. 7 hours after endotoxin administration, the animals were killed with an overdose of pentobarbital sodium. Tissues were prepared, immediately frozen in liquid nitrogen and stored at -80° C until isolation of RNA.
Isolation of RNA, Northern blots and real time PCR
RNA was isolated from THP-1 cell pellets and rat tissues, which were ground under liquid nitrogen using a mortar, with the guanidium thiocyanate method (13). RNA from HUVEC 
RESULTS

L-Phenylalanine stimulates human recombinant GTP cyclohydrolase I in presence of GFRP
Since all work on the action of GFRP had been done thus far with rat enzymes, and since we wanted to study GFRP expression in human cells, we first cloned and expressed human GFRP and studied its action on human recombinant GTP cyclohydrolase I. As is shown in 
LPS down-regulates GFRP mRNA in THP-1 cells, in HUVEC and in rat tissues
Next we studied expression of GFRP mRNA in conditions known to induce GTP cyclohydrolase I by Northern blot in THP-1 cells in relation to glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Fig 2A) . While interferon-gamma alone had no effect on the expression of GFRP (97 ± 31 % of control), LPS (37 ± 15 % of control) and interferongamma plus LPS (42 ± 16 % of control) significantly (P< 0.05, Student's t-test) suppressed GFRP expression in THP-1 cells. This effect of LPS appeared not to be mediated by interleukin-1ß, which had no effect on GFRP expression in THP-1 cells ( Fig. 2A) . A dose of 0.1 pg/ml LPS was sufficient to cause a significant suppression of GFRP mRNA (P < 0. (44 ± 33 % of control, P < 0.05, and 43 ± 19 % of control P < 0.02, respectively, Student's ttest). Interleukin-1 ß, in contrast, had no significant effect on GFRP expression (not shown).
Next we determined GFRP mRNA levels in rats treated with LPS by real time PCR in relation to 18 S RNA. GFRP mRNA in tissues from control animals was highest in liver (2.7 ± 0.5 RNA copies per million 18 S RNA copies), followed by spleen (0.48 ± 0.08), lung (0.045 ± 0.011) and brain (0.033 ± 0.011). Seven hours post intraperitoneal LPS-treatment, GFRP mRNA levels were significantly lower in liver, spleen and lung (P < 0.0001 each, Student's t-test, Fig. 3 ). The slight decrease of GFRP mRNA levels seen in brain was not statistically significant.
LPS renders interferon-gamma-induced neopterin formation by THP-1 cells independent of L-phenylalanine concentrations
Finally, we wanted to see whether the down-regulation of GFRP mRNA had functional consequences for GTP cyclohydrolase I activities in THP-1 cells. For this purpose, we (Fig. 4B ). L-Phenylalanine had no effect on the cell viability in either type of stimulation ( Fig. 4C and Fig 4D) . The other amino acids tested, i.e. L-tyrosine, L-tryptophan and L-arginine, had no effect on formation of neopterin by THP-1 cells (not shown).
DISCUSSION
In the present paper we studied the influence of proinflammatory stimuli on the expression of GFRP. We show that LPS down-regulates expression of GFRP in two cultured human cells as well as in rats treated with LPS in vivo. This finding was unexpected, since we had anticipated that GFRP would be induced together with the protein it regulates, i.e. with GTP cyclohydrolase I. In case of LPS stimulation just the opposite is the case. Parallel to the strong induction of GTP cyclohydrolase I, GFRP mRNA is down-regulated. This renders GTP cyclohydrolase I activity in the cells independent of the metabolic control by L-phenylalanine.
A goal of the induction of GTP cyclohydrolase I by proinflammatory stimuli is to provide sufficient tetrahydrobiopterin for optimal formation of nitric oxide from L-arginine by the inducible isoform of nitric oxide synthase (10), which is induced in parallel to GTP cyclohydrolase I (7). By down-regulation of GFRP, accumulation of tetrahydrobiopterin in cells is potentially maximized due to down-regulation of the feedback inhibitory mechanism.
In addition, the metabolic control by phenylalanine, which is not required in the context of immunologically triggered nitric oxide formation, is switched off.
The time-course of the down-regulation of GFRP mRNA by LPS (Fig. 2C ) and mRNA stability data (Fig. 2D ) suggest that this down-regulation is caused by decreased transcription of GFRP mRNA. Unfortunately, the expression of GFRP in the cells is too low to allow for a direct examination of transcription rates by nuclear run on assays due to sensitivity limitations. In our rat experiments, we found significant decreases of GFRP upon LPS treatment in all organs investigated except for the brain. The reason for this exception might be that LPS is applied intraperitoneally to the animals, and that the blood-brain barrier protects the brain from most of this peripherally administered LPS.
This paper is the first to describe regulation of human GTP-cyclohydrolase I by human GFRP, all other studies had been done with the corresponding rat proteins. Consistent with our observations of neopterin formation by intact THP-1 cells, we find that phenylalanine not only overcomes feedback inhibition by tetrahydrobiopterin, but is also a stimulator of GTP cyclohydrolase I activity in the absence of added tetrahydrobiopterin. This is in line with observations on GFRP expressing serotonin neurons (14), as well as on purified rat proteins (15). Compared to previous studies (2-4) we needed somewhat higher tetrahydrobiopterin concentrations to achieve feedback inhibition of GTP cyclohydrolase I, which may be explained by different experimental conditions rather than by differences in the enzymatic properties. In contrast to these previous studies (2-4), we used standard GTP cyclohydrolase I assay conditions, i.e. saturating levels of GTP (2 mM instead of 0.2 mM) and higher salt concentrations (0.3 M KCl instead of 0.1 M KCl) to ensure a specific interaction of the components and to avoid artifacts due to GTP limitation.
While treatment of THP-1 cells with LPS in addition to interferon-gamma abolished the stimulating effect of phenylalanine, the feedback inhibition by sepiapterin apparently did not change. Similarly, dopamine neurons, which did not express GFRP and showed tetrahydrobiopterin levels unaltered by phenylalanine, were still susceptible to feedback inhibition by dihydroneopterin (14). Thus, either low levels of GFRP still mediated feedback inhibition by pterins but can no longer mediate phenylalanine effects, or yet unknown proteins different from GFRP may be responsible for this effect. were calculated by the Student's t-test. Actinomycin-D was then added, the cells were harvested at the indicated time points post Actinomycin-D treatment, and GFRP mRNA was quantified in relation to 18 S RNA by realtime PCR as described in Experimental Procedures. Statistical differences from untreated controls (see also text) were calculated by the Student's t-test ( § P < 0.05; # P < 0.01; ¶ P < 0.001). This article cites 0 references, 0 of which can be accessed free at
